Gedea Biotech AB

An antibiotic-free and safe treatment of vaginal infections

  • Stage Prototype Ready
  • Industry Consumer Products
  • Location Lund, Sweden
  • Currency SEK
  • Founded January 2015
  • Employees 1
  • Incorporation Type C-corp
  • Website gedeabiotech.com

Company Summary

Gedea Biotech develops antibiotic-free and safe local treatments of bacterial and fungal infections. The treatment is based on a natural substance that is known to be safe. Due to the novel mode of action it has a reduced risk of inducing treatment resistance. The first product will be a pessary for treatment of vaginal fungal infections to be market launched in 2019/20 as an OTC. The total market is 15 billion SEK.

Team

  • Ulf Ellervik
    CSO, prof in bio-organic Chemistry, Lund University

    Responsible for research and development as well as patent. Co-founder of the Company.

  • Helena Strevens
    CMO

    PhD, senior physician in gynaecology and obstetrics, Skåne University hospital. Co-founder of the Project.

  • Olov Sterner
    Chairman of the board

    Prof. in organic Chemistry and cofounder of the Company. Highly experienced in starting up Life science companies.

  • Sophie Manner
    Experimental research

    PhD, Researcher in organic Chemistry, co-founder of the Company. Responsible for experimental research.

  • Christine Widstrand
    Board member

    Vice President Lund University Holding, PhD in analytical Chemistry,

  • Annette Säfholm
    CEO

    PhD in exp.pathology, co-founder of WNT Research AB, 9 years of Project management and business development within Life science.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free